Pumper_Sue
Well-Known Member
- Relationship to Diabetes
- Type 1
Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
New results from the National Health and Wellness Survey show patients with type 1 diabetes have significantly lower HbA1C levels.
Patients with type 1 diabetes (T1D) who are treated with insulin pump therapy have better glycemic control as measured by significantly lower HbA1C levels than patients with T1D who treat their condition with insulin injections, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health. The research was presented at the 18th Annual International Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in New Orleans.
?Patients with type 1 diabetes who have better access to healthcare are more likely to use insulin pump therapy, but even after adjusting for these differences in multivariable modeling we found that insulin pump therapy is a significant predictor of patients? clinical outcomes,? said Shaloo Gupta, MS, senior research analyst with Kantar Health. ?In particular, patients with type 1 diabetes using insulin pump therapy are more likely to control their diabetes than those who are taking insulin injections.?
http://www.prweb.com/releases/2013/5/prweb10743580.htm
New results from the National Health and Wellness Survey show patients with type 1 diabetes have significantly lower HbA1C levels.
Patients with type 1 diabetes (T1D) who are treated with insulin pump therapy have better glycemic control as measured by significantly lower HbA1C levels than patients with T1D who treat their condition with insulin injections, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health. The research was presented at the 18th Annual International Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in New Orleans.
?Patients with type 1 diabetes who have better access to healthcare are more likely to use insulin pump therapy, but even after adjusting for these differences in multivariable modeling we found that insulin pump therapy is a significant predictor of patients? clinical outcomes,? said Shaloo Gupta, MS, senior research analyst with Kantar Health. ?In particular, patients with type 1 diabetes using insulin pump therapy are more likely to control their diabetes than those who are taking insulin injections.?
http://www.prweb.com/releases/2013/5/prweb10743580.htm